Literature DB >> 18652903

Morphology and evolution of cortical lesions in multiple sclerosis. A longitudinal MRI study.

Massimiliano Calabrese1, Massimo Filippi, Marco Rovaris, Irene Mattisi, Valentina Bernardi, Matteo Atzori, Alice Favaretto, Luigi Barachino, Luciano Rinaldi, Chiara Romualdi, Paola Perini, Paolo Gallo.   

Abstract

Cortical lesions (CLs) can be detected in the majority of patients with established multiple sclerosis (MS), but little is known about their evolution over time. This study was performed to investigate the short-term MRI evolution of CLs, with the ultimate aim to achieve a better in vivo understanding of their nature. Seven hundred and sixty-eight CLs from 107 MS patients (76 with relapsing-remitting [RR] and 31 with secondary progressive [SP] MS) were followed with brain MR examinations, including a double inversion recovery (DIR) sequence, every 6 months for 1 year. CLs' number, volume and morphological features were assessed at each time-point. Six hundred and eighty CLs (88.5%) remained morphologically unchanged during the follow-up period, while 74 (9.6%) showed an increase in size. Only 6 (0.8%) CLs seen at baseline (all in RRMS patients) disappeared at follow-up MRI scans. No enlarging CLs spread into the subcortical white matter. No CLs ever showed gadolinium enhancement. At baseline, the mean number of CLs was higher in SPMS than in RRMS patients (p<0.001), whereas the mean number of new CLs per patient after 1 year did not differ between the two groups. Over a one-year period, CLs can increase their number and size in a relevant proportion of MS patients, without spreading into the subcortical white matter or showing inflammatory features similar to those of white matter lesions. The short-term rate of CLs accumulation does not seem to vary according to the clinical stage of MS.

Entities:  

Mesh:

Year:  2008        PMID: 18652903     DOI: 10.1016/j.neuroimage.2008.06.028

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  17 in total

1.  Cerebral Vasoreactivity as an Indirect MRI Marker of White Matter Tracts Alterations in Multiple Sclerosis.

Authors:  Jeremy Deverdun; Arthur Coget; Xavier Ayrignac; Clarisse Carra-Dalliere; Alexandre Krainik; Aude Metzger; Pierre Labauge; Nicolas Menjot de Champfleur; Emmanuelle Le Bars
Journal:  Brain Topogr       Date:  2021-01-23       Impact factor: 3.020

Review 2.  MR imaging of gray matter involvement in multiple sclerosis: implications for understanding disease pathophysiology and monitoring treatment efficacy.

Authors:  Massimo Filippi; M A Rocca
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-31       Impact factor: 3.825

3.  Thalamic lesions in multiple sclerosis by 7T MRI: Clinical implications and relationship to cortical pathology.

Authors:  Daniel M Harrison; Jiwon Oh; Snehashis Roy; Emily T Wood; Anna Whetstone; Michaela A Seigo; Craig K Jones; Dzung Pham; Peter van Zijl; Daniel S Reich; Peter A Calabresi
Journal:  Mult Scler       Date:  2015-01-12       Impact factor: 6.312

4.  Identification and clinical impact of multiple sclerosis cortical lesions as assessed by routine 3T MR imaging.

Authors:  A Mike; B I Glanz; P Hildenbrand; D Meier; K Bolden; M Liguori; E Dell'Oglio; B C Healy; R Bakshi; C R G Guttmann
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-10       Impact factor: 3.825

5.  Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.

Authors:  Nicola S Orefice; Mireille Alhouayek; Antonio Carotenuto; Silvana Montella; Franscesco Barbato; Albert Comelli; Antonio Calignano; Giulio G Muccioli; Giuseppe Orefice
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

6.  A case of epilepsy in multiple sclerosis: Three-dimensional double inversion recovery sequences revealed cortical dysplasia.

Authors:  Domenico S Zimatore; Mirko Trentadue; Marco Castellaro; Monica Ferlisi; Enrico Piovan; Massimiliano Calabrese
Journal:  Neuroradiol J       Date:  2017-04-05

7.  Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis.

Authors:  Daniel M Harrison; Snehashis Roy; Jiwon Oh; Izlem Izbudak; Dzung Pham; Susan Courtney; Brian Caffo; Craig K Jones; Peter van Zijl; Peter A Calabresi
Journal:  JAMA Neurol       Date:  2015-09       Impact factor: 18.302

8.  Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study.

Authors:  Denis Peruzzo; Marco Castellaro; Massimiliano Calabrese; Elisa Veronese; Francesca Rinaldi; Valentina Bernardi; Alice Favaretto; Paolo Gallo; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2012-12-19       Impact factor: 6.200

Review 9.  Susceptibility-weighted imaging: technical aspects and clinical applications, part 2.

Authors:  S Mittal; Z Wu; J Neelavalli; E M Haacke
Journal:  AJNR Am J Neuroradiol       Date:  2009-01-08       Impact factor: 3.825

10.  Neuroinflammatory component of gray matter pathology in multiple sclerosis.

Authors:  Elena Herranz; Costanza Giannì; Céline Louapre; Constantina A Treaba; Sindhuja T Govindarajan; Russell Ouellette; Marco L Loggia; Jacob A Sloane; Nancy Madigan; David Izquierdo-Garcia; Noreen Ward; Gabriel Mangeat; Tobias Granberg; Eric C Klawiter; Ciprian Catana; Jacob M Hooker; Norman Taylor; Carolina Ionete; Revere P Kinkel; Caterina Mainero
Journal:  Ann Neurol       Date:  2016-10-25       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.